Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma

NCT05488366 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: Pembrolizumab
RADIATION: Radiation therapy

Sponsor

University of California, Irvine